Literature DB >> 29408973

Analyzing Analgesic Medications in Community-Dwelling Older Adults.

Ann L Horgas1, Urszula Snigurska1, Michelle Z Farland2, Michael Marsiske3.   

Abstract

Objectives: Analyzing medication data for research purposes is complex, and methods are rarely described in the literature. Our objective was to describe methods of quantifying opioid and nonopioid analgesics and to compare the utility of five different analgesic coding methods when analyzing relationships between pain, analgesic use, and clinical outcomes. In this study, we used physical function as the outcome variable for its clinical relevance and its relationship to pain in older adults. Design: Secondary analyses of baseline cross-sectional data from the Advanced Cognitive Training Interventions for Vital Elders (ACTIVE) study. Setting: Community settings in six regions of the United States. Subjects: A total of 2,802 community-residing adults older than age 65 years.
Methods: A medication audit was conducted. Analgesics were coded as any pain medication, counts (total analgesics, number of opioids and nonopioids), equianalgesics (oral morphine equivalents, oral acetaminophen equivalents), and dose categories. Adjuvant medications used to treat pain (e.g., tricyclic antidepressants and anticonvulsants) and low-dose aspirin typically used for cardiovascular conditions were excluded from these analyses. To examine the utility of these various approaches, a series of hierarchical regression models were conducted with pain and analgesics as predictors and physical functioning as the dependent variable.
Results: Eighty-one point nine percent of participants reported experiencing recent pain, but 26% reported analgesic use. Nonopioids were the most common drug class used. Models revealed that pain was significantly associated with worse physical function (β = -0.45, P = 0.001), after controlling for demographic and analgesic variables. Two basic drug coding methods (e.g., any pain medication, number of pain medications) were equivalent in their explanatory power (β = -0.12, P = 0.001) and were slightly stronger predictors of function than the more complex coding procedures. Conclusions: Analgesic medications are important variables to consider in community-based studies of older adults. We illustrate several methods of quantifying analgesic medications for research purposes. In this community-based sample, we found no advantage of complex equianalgesic coding methods over simple counts in predicting physical functioning. The results may differ depending on the research question or clinical outcome studied. Thus, methods of analyzing analgesic drug data warrant further research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29408973      PMCID: PMC6329439          DOI: 10.1093/pm/pnx340

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  16 in total

1.  ACTIVE: a cognitive intervention trial to promote independence in older adults.

Authors:  J B Jobe; D M Smith; K Ball; S L Tennstedt; M Marsiske; S L Willis; G W Rebok; J N Morris; K F Helmers; M D Leveck; K Kleinman
Journal:  Control Clin Trials       Date:  2001-08

2.  Pain assessment in persons with dementia: relationship between self-report and behavioral observation.

Authors:  Ann L Horgas; Amanda F Elliott; Michael Marsiske
Journal:  J Am Geriatr Soc       Date:  2008-11-18       Impact factor: 5.562

3.  Pharmacological management of persistent pain in older persons.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2009-07-02       Impact factor: 5.562

4.  Pharmacology of opioids in the treatment of chronic pain syndromes.

Authors:  Ricardo Vallejo; Robert L Barkin; Victor C Wang
Journal:  Pain Physician       Date:  2011 Jul-Aug       Impact factor: 4.965

Review 5.  Pain management in the elderly.

Authors:  Monica Malec; Joseph W Shega
Journal:  Med Clin North Am       Date:  2014-12-24       Impact factor: 5.456

6.  Pain and pain medication use in community-dwelling older adults.

Authors:  Patricia Sawyer; Eric V Bodner; Christine S Ritchie; Richard M Allman
Journal:  Am J Geriatr Pharmacother       Date:  2006-12

7.  Analgesic use for knee and hip osteoarthritis in community-dwelling elders.

Authors:  Zachary A Marcum; Subashan Perera; Julie M Donohue; Robert M Boudreau; Anne B Newman; Christine M Ruby; Stephanie A Studenski; C Kent Kwoh; Eleanor M Simonsick; Doug C Bauer; Suzanne Satterfield; Joseph T Hanlon
Journal:  Pain Med       Date:  2011-10-12       Impact factor: 3.750

8.  Predictors of postoperative movement and resting pain following total knee replacement.

Authors:  Barbara A Rakel; Nicole Petsas Blodgett; Bridget M Zimmerman; Nyla Logsden-Sackett; Charles Clark; Nicolas Noiseux; John Callaghan; Keela Herr; Katharine Geasland; Xiaoyan Yang; Kathleen A Sluka
Journal:  Pain       Date:  2012-07-25       Impact factor: 6.961

9.  Effects of an analgesic trial in reducing pain behaviors in community-dwelling older adults with dementia.

Authors:  Amanda Floetke Elliott; Ann L Horgas
Journal:  Nurs Res       Date:  2009 Mar-Apr       Impact factor: 2.381

Review 10.  Special issues in the management of chronic pain in older adults.

Authors:  Patricia Bruckenthal; M Carrington Reid; Lori Reisner
Journal:  Pain Med       Date:  2009-07       Impact factor: 3.750

View more
  3 in total

1.  Patterns and predictors of chronic opioid use in older adults: A retrospective cohort study.

Authors:  GYeon Oh; Erin L Abner; David W Fardo; Patricia R Freeman; Daniela C Moga
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

2.  Spinal manipulative therapy and exercise for older adults with chronic low back pain: a randomized clinical trial.

Authors:  Craig Schulz; Roni Evans; Michele Maiers; Karen Schulz; Brent Leininger; Gert Bronfort
Journal:  Chiropr Man Therap       Date:  2019-05-15

3.  Pain in Older Adults With Dementia: A Survey in Spain.

Authors:  Lydia Giménez-Llort; Maria Luisa Bernal; Rachael Docking; Aida Muntsant-Soria; Virginia Torres-Lista; Antoni Bulbena; Patricia A Schofield
Journal:  Front Neurol       Date:  2020-11-20       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.